Category Archives: Eczema

GUERLAIN Abeille Royal Youth Watery Oil When it comes to caring for extra sensitive skin or easing discomfort, honey is the natural ingredient that first comes to mind. In high school when acne and oily skin were the main concerns, tea tree was the cure-all. By the time I began working and had to constantly deal with dry skin, sensitivities and unexpected breakouts, a work colleague introduced me to the wonders of honey. Continue reading →

In the world of skin care, there are a few core skin-type terms that get thrown around pretty frequently namely, oily, combination, dry, acne-prone, and sensitive skin. Continue reading →

Analytical Research Cognizance has announced the addition of the Eczema Skin-Care Products Market by company, by country, and by application/type for the competitive landscape analysis. Get Latest Sample for Global Eczema Skin-Care Products Market Report @ https://www.arcognizance.com/enquiry-sample/690626 Scope of the Report: The worldwide market for Eczema Skin-Care Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, . Continue reading →

If you're one to get red, inflamed, angry patches on the eyelid, you know contact dermatitis all too well. "The most common type of facial eczema is contact dermatitisthis is a form of eczema that comes from irritation from products, like perfumes or skin care topicals," says holistic dermatologist Alan Dattner, M.D. "It's most often found around the eyes and eyelids." If this is you, or you've had a brush with facial eczema before, you've probably been told to reach for sensitive-skin-safe makeup items and eye creams Continue reading →

Childhood eczema affects 30 per cent of Aussie kids but treatment options are limited, leaving parents to try everything they can to ease the agonising pain. Continue reading →

JUPITER, Fla., Dec. 2, 2019 /PRNewswire/ -- Today CBD Brands, a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (CBD) via a multitude of convenient products, announced that it has initiated a clinical study to investigate the efficacy and safety of its proprietary CBD infused lotion formulations in the treatment of atopic dermatitis (eczema). The study is a double-blinded placebo controlled study with a total population of 90 subjects to be enrolled Continue reading →

By Chris Lange December 2, 2019 10:15 am Aslan Pharmaceuticals Ltd. (NASDAQ: ASLN) shares jumped on Monday after the firm announced positive preliminary data from the lowest dose cohort of its ongoing multiple ascending dose study of ASLAN004 for the treatment of moderate-to-severe atopic dermatitis. For this preliminary data, the firm reviewed unclean blinded data, including the Eczema Area and Severity Index scores of the three patients that have completed at least one month of dosing Continue reading →

For those who have sensitive skin or are prone to a host of skin disorders, a UK winter could be particularly challenging. With temperature warnings from the Met Office saying it could fall below freezing next week, the cold weather could wreak havoc for those who have sensitive skin. Continue reading →

As Sanofi Genzyme and Regeneron continue to add indications for their next-gen immunology treatment Dupixent, the partners have created a separateunbranded campaign to raise overall awarenessabout type 2 inflammation and its connections across multiple diseases and conditions. The HCP-targeted Type 2 Inflammation Connection debuted at the European Respiratory Society International Congress in Octoberas the first of a planned series of events at medical congresses around the world. Its goal is to bring attention to type 2 inflammation, specifically among advocacy groups and the media, as it's a relatively new therapy area. Continue reading →

Patients with moderate-to-severe atopic dermatitis may have a 20% increased risk of atrial fibrillation, suggests a study published in the Journal of the American Academy of Dermatology.1 Atrial fibrillation is common affecting 4% of individuals 60 years or older and carries with it an increased risk of stroke.2 Research has shown that inflammation is significant risk factor for developing atrial fibrillation, as patients with inflammatory disease such as rheumatoid arthritis, psoriasis or individuals with inflammatory biomarkers have been shown to be have an increased risk of atrial fibrillation.3,4 RELATED:More evidence of cardiovascular disease in atopic eczema The authors of the study speculated that patients with atopic dermatitis might also have an increased risk for atrial fibrillation because of the presence of low-grade inflammation due to the disease and the increased prevalence of cardiovascular risk factors, such as obesity, hypertension and diabetes, among this group.5,6 To test their hypothesis, they conducted a nationwide population-based 35-year cohort study to examine whether patients in Denmark with hospital-diagnosed moderate-to-severe atopic dermatitis were at long-term increased risk of atrial fibrillation. Using the Danish National Patient Registry (DNPR) they identified patients born in Denmark between January 1, 1947 and January 1, 1983 who had received a hospital diagnosis of atopic dermatitis from January 1, 1977 until January 1 2013 and matched each with ten individuals of the same sex and birth year. Patients were followed up until death, emigration, atrial fibrillation diagnosis or until 2013 Continue reading →